Jonathan Moses1, Ashley Keilman2, Sarah Worley3, Kadakkal Radhakrishnan1, A David Rothner4, Sumit Parikh5. 1. Department of Pediatric Gastroenterology, The Cleveland Clinic, Cleveland, Ohio. 2. Case Western Reserve University, School of Medicine, Cleveland, Ohio. 3. Department of Quantitative Health Sciences, The Cleveland Clinic, Cleveland, Ohio. 4. Center for Pediatric Neurology and Neurosurgery, The Cleveland Clinic, Cleveland, Ohio. 5. Center for Pediatric Neurology and Neurosurgery, The Cleveland Clinic, Cleveland, Ohio; Program for Pediatric Neurometabolism/Neurogenetics, The Cleveland Clinic, Cleveland, Ohio. Electronic address: parikhs@ccf.org.
Abstract
BACKGROUND: Cyclic vomiting syndrome is characterized by repeated, stereotypical vomiting episodes. The diagnosis is made by exclusion of other organic diseases, which can lead to extensive testing. It has been suggested that these patients can have mitochondrial dysfunction. The aim of the study was to examine the evaluation of our cyclic vomiting patients and to determine whether they had associated, undiagnosed metabolic abnormalities. METHODS: This retrospective study included 106 patients aged <21 years at diagnosis. Information regarding medical history, laboratory, and imaging studies were collected. Metabolic studies in plasma and urine were obtained when patients were well and when patients were in a vomiting cycle, including plasma amino acids, acylcarnitines, and urine organic acids. RESULTS: The mean age at diagnosis was 8.9 ± 5.0 years. Neuroimaging revealed previously unknown intracranial abnormalities in <10% of patients, none of whom explained the vomiting signs. Abdominal ultrasounds revealed abnormalities in 15% of patients during an acute episode and 7% of patients when well. Sixty-one patients had an upper gastrointestinal series, all of which were normal. A total of 92% of patients had laboratory testing with 38% indicating abnormalities possibly suggesting mitochondrial dysfunction. CONCLUSIONS: This large, single-center study further evaluated the need for more focused evaluation in patients with suspected cyclic vomiting syndrome. Thirty-eight percent of our patients had abnormalities in blood and/or urine suggesting mitochondrial dysfunction, which requires more detailed investigation in the future.
BACKGROUND:Cyclic vomiting syndrome is characterized by repeated, stereotypical vomiting episodes. The diagnosis is made by exclusion of other organic diseases, which can lead to extensive testing. It has been suggested that these patients can have mitochondrial dysfunction. The aim of the study was to examine the evaluation of our cyclic vomitingpatients and to determine whether they had associated, undiagnosed metabolic abnormalities. METHODS: This retrospective study included 106 patients aged <21 years at diagnosis. Information regarding medical history, laboratory, and imaging studies were collected. Metabolic studies in plasma and urine were obtained when patients were well and when patients were in a vomiting cycle, including plasma amino acids, acylcarnitines, and urine organic acids. RESULTS: The mean age at diagnosis was 8.9 ± 5.0 years. Neuroimaging revealed previously unknown intracranial abnormalities in <10% of patients, none of whom explained the vomiting signs. Abdominal ultrasounds revealed abnormalities in 15% of patients during an acute episode and 7% of patients when well. Sixty-one patients had an upper gastrointestinal series, all of which were normal. A total of 92% of patients had laboratory testing with 38% indicating abnormalities possibly suggesting mitochondrial dysfunction. CONCLUSIONS: This large, single-center study further evaluated the need for more focused evaluation in patients with suspected cyclic vomiting syndrome. Thirty-eight percent of our patients had abnormalities in blood and/or urine suggesting mitochondrial dysfunction, which requires more detailed investigation in the future.
Authors: Ingeborg P M Hermus; Stacey J B Willems; Aimée C C F Bogman; Paddy K C Janssen; Leonie Brabers; Jan N M Schieveld Journal: Prim Care Companion CNS Disord Date: 2016-05-12